124 related articles for article (PubMed ID: 10480916)
1. Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis.
Malaviya R; Zhu D; Dibirdik I; Uckun FM
J Biol Chem; 1999 Sep; 274(38):27028-38. PubMed ID: 10480916
[TBL] [Abstract][Full Text] [Related]
2. Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactions.
Malaviya R; Uckun FM
Biochem Biophys Res Commun; 1999 Apr; 257(3):807-13. PubMed ID: 10208864
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner.
Linwong W; Hirasawa N; Aoyama S; Hamada H; Saito T; Ohuchi K
Br J Pharmacol; 2005 Jul; 145(6):818-28. PubMed ID: 15852029
[TBL] [Abstract][Full Text] [Related]
4. In vivo pharmacokinetics and anti-anaphylactic activity of the novel mast cell inhibitor 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131).
Malavija R; Chen CL; Liu XP; Uckun FM
Am J Ther; 2001; 8(1):35-9. PubMed ID: 11304656
[TBL] [Abstract][Full Text] [Related]
5. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97).
Malaviya R; Chen CL; Navara C; Malaviya R; Liu XP; Keenan M; Waurzyniak B; Uckun FM
J Pharmacol Exp Ther; 2000 Dec; 295(3):912-26. PubMed ID: 11082424
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
[TBL] [Abstract][Full Text] [Related]
7. Quantitative high-performance liquid chromatographic method for pharmacokinetic studies of the potent mast cell inhibitor 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P131).
Chen CL; Malaviya R; Chen H; Liu XP; Uckun FM
J Chromatogr B Biomed Sci Appl; 1999 Apr; 727(1-2):205-12. PubMed ID: 10360439
[TBL] [Abstract][Full Text] [Related]
8. Tec family kinases: regulation of FcεRI-mediated mast-cell activation.
Ellmeier W; Abramova A; Schebesta A
FEBS J; 2011 Jun; 278(12):1990-2000. PubMed ID: 21362140
[TBL] [Abstract][Full Text] [Related]
9. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazoline.
Uckun FM; Ek O; Liu XP; Chen CL
Clin Cancer Res; 1999 Oct; 5(10):2954-62. PubMed ID: 10537365
[TBL] [Abstract][Full Text] [Related]
10. Methoxychlor enhances degranulation of murine mast cells by regulating FcεRI-mediated signal transduction.
Yasunaga S; Nishi K; Nishimoto S; Sugahara T
J Immunotoxicol; 2015; 12(3):283-9. PubMed ID: 25418051
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
12. The orphan nuclear receptor NR4A1 promotes FcεRI-stimulated mast cell activation and anaphylaxis by counteracting the inhibitory LKB1/AMPK axis.
Jin F; Li X; Deng Y; Timilshina M; Huang B; Kim DY; Chang JH; Ichinose H; Baek SH; Murakami M; Lee YJ; Chang HW
Allergy; 2019 Jun; 74(6):1145-1156. PubMed ID: 30565708
[TBL] [Abstract][Full Text] [Related]
13. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation.
Tibbles HE; Vassilev A; Wendorf H; Schonhoff D; Zhu D; Lorenz D; Waurzyniak B; Liu XP; Uckun FM
J Biol Chem; 2001 May; 276(21):17815-22. PubMed ID: 11278899
[TBL] [Abstract][Full Text] [Related]
14. 2,4,6-Trihydroxy-alpha-p-methoxyphenylacetophenone (Compound D-58) is a potent inhibitor of allergic reactions.
Malaviya R; Vassilev A; Uckun FM
Am J Ther; 2001; 8(6):417-24. PubMed ID: 11704780
[TBL] [Abstract][Full Text] [Related]
15. Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model.
Uckun FM; Roers BA; Waurzyniak B; Liu XP; Cetkovic-Cvrlje M
Blood; 2002 Jun; 99(11):4192-9. PubMed ID: 12010825
[TBL] [Abstract][Full Text] [Related]
16. Role of Janus kinase-2 in IgE receptor-mediated leukotriene C4 production by mast cells.
Sur R; Hall J; Cavender D; Malaviya R
Biochem Biophys Res Commun; 2009 Dec; 390(3):786-90. PubMed ID: 19835845
[TBL] [Abstract][Full Text] [Related]
17. Polydatin (PD) inhibits IgE-mediated passive cutaneous anaphylaxis in mice by stabilizing mast cells through modulating Ca²⁺ mobilization.
Yuan M; Li J; Lv J; Mo X; Yang C; Chen X; Liu Z; Liu J
Toxicol Appl Pharmacol; 2012 Nov; 264(3):462-9. PubMed ID: 22959927
[TBL] [Abstract][Full Text] [Related]
18. Both adhesion to immobilized vitronectin and FcepsilonRI cross-linking cause enhanced focal adhesion kinase phosphorylation in murine mast cells.
Bhattacharyya SP; Mekori YA; Hoh D; Paolini R; Metcalfe DD; Bianchine PJ
Immunology; 1999 Nov; 98(3):357-62. PubMed ID: 10583594
[TBL] [Abstract][Full Text] [Related]
19. Camellia japonica suppresses immunoglobulin E-mediated allergic response by the inhibition of Syk kinase activation in mast cells.
Lee JH; Kim JW; Ko NY; Mun SH; Kim DK; Kim JD; Kim HS; Lee KR; Kim YK; Radinger M; Her E; Choi WS
Clin Exp Allergy; 2008 May; 38(5):794-804. PubMed ID: 18261158
[TBL] [Abstract][Full Text] [Related]
20. Targeting mast cells in endometriosis with janus kinase 3 inhibitor, JANEX-1.
D'Cruz OJ; Uckun FM
Am J Reprod Immunol; 2007 Aug; 58(2):75-97. PubMed ID: 17631002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
